QuantumCURE Pro v5 — Breaking Into New Chemical Space
- mansour ansari
- Sep 9
- 1 min read
Version 5 QuantumCURE Pro, Citizen Scientist Desktop and mobile versions --- Breaking Into New Chemical Space
I'm excited to announce QuantumCURE v5, the latest and most advanced release of our quantum-powered drug discovery platform.
For the first time, QuantumCURE now integrates Bemis–Murcko scaffolding — a powerful computational chemistry technique developed by Guy Bemis and Mark Murcko. This method reduces each compound to its core structural framework, stripping away sidechains and leaving only the ring systems and connecting atoms.
Why does this matter? Because scaffolds are the true backbone of drug discovery. They reveal whether a candidate belongs to a known chemical family or represents an entirely new framework. By combining scaffolding with our quantum entropy pipeline, QuantumCURE can now:
Visualize scaffolds for every docked compound, side-by-side with the original molecule.
Score novelty by comparing against FDA-approved and ChEMBL scaffolds using similarity metrics (e.g., Tanimoto index).
Highlight unexplored chemical space, flagging scaffold families that are structurally distinct from known drugs.
Tag discoveries symbolically with Zaban glyphs, turning novelty into a compact, interpretable code.
This upgrade transforms QuantumCURE from a docking engine into a medicinal chemistry innovation engine. Version 5 not only screens molecules but also discovers new structural backbones — the raw material of tomorrow’s medicines.
With this release, QuantumCURE demonstrates its ability to expand the chemical universe, giving researchers and investors alike a clear view of how quantum entropy uncovers pathways that deterministic methods miss.
See my work here:
and
-------------------------------
#QuantumComputing #DrugDiscovery #QuantumCURE #AIinPharma #MedicinalChemistry #QuantumBiology #QuantumEntropy #PharmaInnovation #ComputationalChemistry #QuantumTech #DrugDevelopment #BiomedicalInnovation #LifeSciences #QuantumFuture #NextGenPharma
Comments